ClinConnect ClinConnect Logo
Search / Trial NCT05943509

Hearing Program in Primary Care

Launched by NYU LANGONE HEALTH · Jul 5, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Hearing Program in Primary Care," is looking into how to better support people with hearing loss during their visits to primary care doctors. The study aims to find out whether providing counseling on useful listening devices, like hearing aids or personal amplifiers, is more helpful than just referring patients to regular hearing specialists. Participants will be chosen at random to receive either the counseling or the traditional referral.

To be eligible for this trial, participants need to be between 21 and 914 years old, able to speak English or Spanish, and capable of giving consent to join the research. However, individuals who already use hearing aids or cochlear implants cannot participate. If you take part in this study, you can expect to receive support tailored to your hearing needs and contribute to important research that could improve care for others with similar conditions. The trial is currently recruiting participants, and anyone interested should reach out for more information.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • speaks English or Spanish;
  • capacity to consent to research
  • Exclusion Criteria:
  • • has or uses hearing aids or cochlear implants

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

David Friedmann

Principal Investigator

NYU Langone Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported